Santogen Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.75 M
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
About Santogen Pharma
Santogen Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2023 (One year and five months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Singh, Pramod Singh, Shyamadutta Satpathy, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721TS2023PTC176613
-
Company No.
176613
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2023
-
Date of AGM
30 Nov 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Who are the key members and board of directors at Santogen Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Singh
|
Director | 30-Aug-2023 | Current |
|
Pramod Singh
|
Director | 30-Aug-2023 | Current |
|
Shyamadutta Satpathy
|
Director | 30-Aug-2023 | Current |
|
Suraj Prakash
|
Director | 30-Aug-2023 | Current |
Financial Performance of Santogen Pharma.
Enhance accessibility to Santogen Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Santogen Pharma?
Unlock access to Santogen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Spd Infradevelopers Private LimitedMukesh Singh and Pramod Singh are mutual person
-
Spd Inframin LlpMukesh Singh and Pramod Singh are mutual person
-
Stambh Associates Private Limited
Mukesh Singh is a mutual person
-
Spd Corporate Advisors Private Limited
Mukesh Singh is a mutual person
-
Mid Shot Entertainment Private Limited
Mukesh Singh is a mutual person
-
Birsa Munda Foundation
Mukesh Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Santogen Pharma?
Unlock and access historical data on people associated with Santogen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Santogen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santogen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.